| 1-DP2-EB035891-01 |
A Novel Class of Synthetic Receptors to Empower the Age of mRNA Therapies |
Xiaojing Gao |
Stanford University |
| 1-K99-EB036553-01 |
AN ADAPTIVE FRAMEWORK TO SYNTHESIZE AND RECONFIGURE BACTERIAL VIRUSES (PHAGES) TO COUNTER ANTIBIOTIC RESISTANCE |
Yan Zhang |
California Institute of Technology |
| 1-R01-EB031936-01 |
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function |
Ute Hochgeschwender |
Central Michigan University |
| 1-R01-EB036493-01 |
Non-invasive and Long-lived CNS Delivery of Treg-inducing Cytokine Depots |
Peter Tessier |
University of Michigan at Ann Arbor |
| 1-R01-EB037025-01 |
Synthetic RNA Switch-Based Temporal and Dose Control of in Vivo Gene Therapies |
Guocai Zhong |
Univ of Massachusetts Med Sch Worcester |
| 1-R01-EB037456-01 |
A molecular toolbox for thermal control of programmed cell death in animals |
Lukasz Bugaj |
University of Pennsylvania |
| 1-R03-EB036096-01 |
Bioengineering of Customized Exosomes as a Cell-free Therapy for Volumetric Muscle Loss Injuries Proposal |
Prabaha Sikder |
Cleveland State University |
| 1-R15-EB035866-01 |
Mitochondrial-targeting Exosomes for Neuroinflammation |
Lanrong Bi |
Michigan Technological University |
| 1-R15-EB036962-01 |
Engineering Natural Killer Cell Derived Extracellular Vesicular Nanodrug for Tumor Targeted Bioimaging and Therapy |
Santosh Aryal |
University of Texas Tyler |
| 1-R21-EB033459-01A1 |
A Novel Vector Platform to Actualize T Cell Modification In Vivo |
David Curiel |
Washington University |
